Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-04-14 Sale | 2025-04-15 8:39 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $14.53 | $165,185 | 219,612 (Direct) | View |
| 2025-04-11 Sale | 2025-04-15 8:36 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,757 | $12.06 | $129,684 | 215,340 (Direct) | View |
| 2025-04-11 Sale | 2025-04-15 8:33 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,319 | $12.19 | $186,803 | 862,289 (Direct) | View |
| 2025-04-01 Sale | 2025-04-03 5:36 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 55,771 | $15.76 | $879,008 | 230,978 (Direct) | View |
| 2025-03-13 Purchase | 2025-03-17 9:05 pm | Mineralys Therapeutics Inc. | MLYS | Samsara BioCapital GP LLC Samsara BioCapital L.P. 10% Owner | 600,000 | $13.5 | $8,100,000 | 5,674,916 (Indirect) | View |
| 2025-03-13 Purchase | 2025-03-17 9:04 pm | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Director | 600,000 | $13.5 | $8,100,000 | 5,674,916 (Indirect) | View |
| 2025-03-13 Purchase | 2025-03-17 7:56 pm | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 1,296,296 | $13.5 | $17,499,996 | 6,147,280 (Indirect) | View |
| 2025-01-13 Sale | 2025-01-15 9:46 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,757 | $9.0977 | $97,864 | 226,097 (Direct) | View |
| 2025-01-13 Sale | 2025-01-15 9:44 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 18,333 | $9.0592 | $166,082 | 877,608 (Direct) | View |
| 2024-11-11 Sale | 2024-11-12 5:25 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,026 | $15 | $75,398 | 285,952 (Direct) | View |
| 2024-11-06 Sale | 2024-11-08 4:21 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 25,482 | $15.03 | $383,066 | 275,926 (Direct) | View |
| 2024-10-11 Sale | 2024-10-15 4:22 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,757 | $13.57 | $146,004 | 236,854 (Direct) | View |
| 2024-10-11 Sale | 2024-10-15 4:21 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,271 | $13.52 | $206,433 | 895,941 (Direct) | View |
| 2024-07-24 Sale | 2024-07-26 9:45 pm | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 550,000 | $13.05 | $7,177,500 | 8,644,579 (Indirect) | View |
| 2024-07-16 Sale | 2024-07-18 6:34 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 525 | $15 | $7,876 | 286,356 (Direct) | View |
| 2024-07-11 Sale | 2024-07-12 4:37 pm | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 10,757 | $13.14 | $141,394 | 247,611 (Direct) | View |
| 2024-07-11 Sale | 2024-07-12 4:36 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 15,746 | $13.34 | $210,075 | 911,212 (Direct) | View |
| 2024-06-17 Sale | 2024-06-20 5:44 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 49,313 | $12.01 | $592,022 | 926,958 (Direct) | View |
| 2024-06-12 Sale | 2024-06-14 6:15 pm | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 72,797 | $12.7 | $924,203 | 976,271 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-14 Exercise | 2025-04-15 8:39 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $0 | 219,612 (Direct) | View |
| 2025-04-14 Exercise | 2025-04-15 8:39 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 219,612 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:36 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 1,606 | $0 | 230,978 (Direct) | View |
| 2025-04-01 Exercise | 2025-04-03 5:36 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 1,606 | $1.08 | 230,978 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-13 5:15 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $0 | 286,749 (Direct) | View |
| 2025-03-12 Exercise | 2025-03-13 5:15 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 286,749 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 9:41 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund III L.P. Kolchinsky Peter Shah Rajeev M. Director | 32,900 | $0 | 32,900 (Indirect) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Levy Adam Scott CFO and Secretary | 170,000 | $0 | 170,000 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 170,000 | $0 | 170,000 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | AKKARAJU SRINIVAS Samsara BioCapital L.P. Director 10% Owner | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 32,900 | $0 | 65,800 (Direct) | View |
| 2025-02-13 Other | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 65,800 | $0 | 65,800 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | DiRocco Derek Director | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:59 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Gold Alexander M Director | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:58 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Congleton Jon Chief Executive Officer | 570,000 | $0 | 570,000 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:58 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | Karydas Daphne Director | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-13 Option Award | 2025-02-24 6:58 pm | N/A 2035-02-13 | Mineralys Therapeutics Inc. | MLYS | SBLENDORIO GLENN Director | 32,900 | $0 | 32,900 (Direct) | View |
| 2025-02-12 Exercise | 2025-02-13 5:29 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $0 | 286,749 (Direct) | View |
| 2025-02-12 Exercise | 2025-02-13 5:29 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 286,749 (Direct) | View |
| 2025-01-13 Exercise | 2025-01-15 9:45 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,367 | $0 | 286,749 (Direct) | View |
| 2025-01-13 Exercise | 2025-01-15 9:45 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 286,749 (Direct) | View |
| 2025-01-13 Exercise | 2025-01-15 9:45 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 286,749 (Direct) | View |
| 2024-05-22 Other | 2025-01-07 5:58 pm | N/A 2034-05-22 | Mineralys Therapeutics Inc. | MLYS | Slingsby Brian Taylor Catalys Pacific Fund LP Director 10% Owner | 44,000 | $0 | 22,000 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 4:37 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0 | 151,026 (Direct) | View |
| 2024-12-11 Exercise | 2024-12-13 4:37 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 151,026 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 5:25 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,043 | $0 | 285,952 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 5:25 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 285,952 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 5:25 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,026 | $1.08 | 285,952 (Direct) | View |
| 2024-11-06 Exercise | 2024-11-08 4:21 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 25,482 | $0 | 275,926 (Direct) | View |
| 2024-11-06 Exercise | 2024-11-08 4:21 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 25,482 | $1.08 | 275,926 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-15 4:22 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,369 | $0 | 316,460 (Direct) | View |
| 2024-10-11 Exercise | 2024-10-15 4:22 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 316,460 (Direct) | View |
| 2024-10-14 Exercise | 2024-10-15 4:22 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,352 | $1.08 | 316,460 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-12 4:32 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,367 | $0 | 316,460 (Direct) | View |
| 2024-09-11 Exercise | 2024-09-12 4:32 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 316,460 (Direct) | View |
| 2024-09-12 Exercise | 2024-09-12 4:32 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 316,460 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-13 4:20 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $0 | 316,460 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-13 4:20 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 316,460 (Direct) | View |
| 2024-08-12 Exercise | 2024-08-13 4:20 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 316,460 (Direct) | View |
| 2024-07-16 Exercise | 2024-07-18 6:34 pm | N/A 2032-07-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 525 | $0 | 286,356 (Direct) | View |
| 2024-07-16 Exercise | 2024-07-18 6:34 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 525 | $1.08 | 286,356 (Direct) | View |
| 2024-07-11 Exercise | 2024-07-12 4:39 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 316,985 (Direct) | View |
| 2024-07-11 Exercise | 2024-07-12 4:39 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 316,985 (Direct) | View |
| 2024-07-12 Exercise | 2024-07-12 4:39 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 316,985 (Direct) | View |
| 2024-06-13 Option Award | 2024-06-17 4:33 pm | N/A 2034-06-13 | Mineralys Therapeutics Inc. | MLYS | Gold Alexander M Director | 44,000 | $0 | 44,000 (Direct) | View |